Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 32 P474 | DOI: 10.1530/endoabs.32.P474

ECE2013 Poster Presentations Diabetes (151 abstracts)

Therapeutic swicht at discharge improves medium term metabolic control in patients with type 2 diabetes and high vascular risk

Francisco Javier Vílchez-López , Maria Belen Ojeda-Schuldt , Isabel Mateo Gavira , Cristina López-Tinoco , Pilar Roldán-Caballero & Manuel Aguilar-Diosdado


Endocrinology Department, University Hospital Puerta del Mar, Cadiz, Spain.


Objective: To evaluate the characteristics and glycemic control in admitted patients with type 2 diabetes and high vascular risk. To analyze therapeutic switch effect at hospital discharge on medium term metabolic control.

Methods: Cross-sectional study including patients with type 2 diabetes and high vascular risk. Demographic and clinical characteristics, laboratory parameters, and diabetes treatment at baseline and discharge were analized. We used a specific insulin protocol during admission, switched treatment at discharge in selected cases and evaluated the metabolic control evolution 3 months after discharge.

Results: 126 patients were included (55.6% male, mean age 64.3 years and mean duration of diabetes 16.3 years). 63.5% had hypertension, 47.6% dyslipidemia and 19% were smokers. 7.1% had a history of stroke, 40.5% coronary heart disease and 36.5% peripheral arteriopathy. Most prevalent causes of admissions: 22.2% amputation, 17.5% coronary bypass, 15.9% valve surgery and 15.1% coronary heart disease. Prior to admission, 38.9% were treated with insulin, 30.2% with oral hypoglycemic agents (OHA) and 25.4% with combinated therapy. At discharge, 45.2% remained their previous treatment, adjusted if necessary and 43.5% started insulin treatment (8.7% basal insulin plus OHA, 7.1% basal insulin, 11.9% biphasic insulins, and 15.9% basal-bolus regimen). Mean HbA1c at admission decreased from 8.9% (18.6% patients, <7%) to 7.49%, (44.2% patients <7%) (P<0.001) 3 months after discharge, with no significant differences detected in the rest of variables analized.

Conclusions: Most hospitalized patients with type 2 diabetes presented with poor glycemic control and chronic complications. Insulin consensus protocol can improve glycemic control during hospitalization. Optimizing therapy at discharge improves medium term metabolic control.

Article tools

My recent searches

No recent searches.